Celecoxib concentration predicts decrease in prostaglandin E(2 )concentrations in nipple aspirate fluid from high risk women

BACKGROUND: Epidemiologic studies suggest that long term low dose celecoxib use significantly lowers breast cancer risk. We previously demonstrated that 400 mg celecoxib taken twice daily for 2 weeks lowered circulating plasma and breast nipple aspirate fluid (NAF) prostaglandin (PG)E(2 )concentrati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sauter, Edward R, Qin, Wenyi, Hewett, John E, Ruhlen, Rachel L, Flynn, John T, Rottinghaus, George, Chen, Yin-Chieh
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2259321/
https://ncbi.nlm.nih.gov/pubmed/18267025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-49
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados